OSS Partners with U.S. Special Operations Command to Develop High Performance edge Computers (HPeC) for Austere Maritime Environments

(NASDAQ:OSS), Partnership to develop rugged edge AI/ML compute solutions to improve cognitive dominance for U.S. Special Operations Forces Agreement aligns with OSS' strategy to expand offerings and establish embedded relationships across the U.S. Department of Defense ESCONDIDO, Calif., May 29, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a […]

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

(NASDAQ:CABA), PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June

Upexi Partners with Crypto-Native Marketing and Design Firm, GMI Digital, to Drive Solana-Focused Strategy

(NASDAQ:UPXI), TAMPA, Fla., May 29, 2025 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today announced that it has selected GMI Digital as its crypto-native marketing and design service provider. As Upexi advances its Solana-first strategy–offering investors

New study shows significant decline in men’s mental health; half lack sufficient social support

Stress and depression risk increase for Canadian men One in two men lack sufficient social support networks Canadian Men's Health Foundation launches #NeverAlone campaign for Men's Health Month in June VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) — At a time of heightened uncertainty across the country, new research shows more men are struggling

Replimune to Present at the 2025 Jefferies Global Healthcare Conference

(NASDAQ:REPL), WOBURN, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management team will present in a fireside chat at the 2025 Jefferies Global Healthcare Conference on Thursday, June 5, 2025 at 4:20

Cocrystal Pharma’s Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza Strain

(NASDAQ:COCP), CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain The Company's virology study further confirmed the previous structural and in vitro data that revealed the binding of CC-42344 to PB2 protein of the 2024 H5N1 avian influenza virus BOTHELL, Wash., May 29, 2025 (GLOBE NEWSWIRE) —

Whitetail Properties Partners With Acres.com to Expand Marketing Efforts Nationwide

Fayetteville, Ark., May 29, 2025 (GLOBE NEWSWIRE) — Acres.com, the complete land intelligence platform, announced its new partnership with Whitetail Properties, a national land brokerage with agents across the country. Today, many Whitetail Properties Land Specialists use Acres' data and tools to support marketing efforts, win more listings, and make informed business decisions. Whitetail Properties

BriteCore Named a Top 25 InsurTech Company of 2025 by The Financial Technology Report

San Mateo, CA, May 29, 2025 (GLOBE NEWSWIRE) — BriteCore, a leading provider of cloud-native core systems for property and casualty (P&C) insurers, today announced that it has been named one of the Top 25 InsurTech Companies of 2025 by The Financial Technology Report. This annual list honors companies that are transforming the insurance industry

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

(NASDAQ:MDAI),(NASDAQ:MDAIW), DALLAS, May 29, 2025 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced results from its 2025 Annual Meeting of Stockholders held earlier today. A total of 15,551,068 shares representing

Beghou Consulting Adds New Partners to Strengthen Market Access, Cell & Gene Therapy, and Technology Capabilities

EVANSTON, Ill., May 29, 2025 (GLOBE NEWSWIRE) — Beghou Consulting, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that highly-regarded industry leaders Robert Rouse and Jason Stephani have joined as partners. Both bring exceptional experience from a mix of life sciences companies and consultancies to their new roles

Scroll to Top